Press & Media

Latest News

Stay up to date with Intralytix's latest product announcements, clinical trial updates, and corporate milestones.

Press Releases

Intralytix Awarded Multimillion-Dollar NIH Grant as Part of University of Pittsburgh’s Centers for Accelerating Phage Therapy to Combat ESKAPE Pathogens

Intralytix, Inc. receives multimillion-dollar Research Program Project (P01) grant from the National Institutes of Health (NIH).

Intralytix receives funding from the Maryland Department of Commerce to advance AI - ML-driven phage manufacturing

Intralytix, Inc., a global leader in bacteriophage technology, has been awarded a Maryland Manufacturing 4.0 grant to enhance its phage manufacturing capabilities through the adoption of advanced Industry 4.0 technologies.

Intralytix and Life Extension Collaborate to Advance Bacteriophage-Based Interventions in the VMS Space

Intralytix is excited to announce a new agreement with Life Extension to co-develop and commercialize a leading-edge phage-based nutraceutical aimed at expanding the role of bacteriophage technology within the vitamins, minerals, and supplements (VMS) sector.

Intralytix Receives FDA CVM Approval for Salmonella-Targeting Phage Preparation for Use in Pet Food Applications

Intralytix, Inc., a global leader in bacteriophage technology, announced today that it has received formal approval from the U.S. Food and Drug Administration’s Center for Veterinary Medicine (FDA CVM) for its Salmonella-specific bacteriophage preparation for use as a processing aid to help control S. enterica in pet food and ingredients for use in pet food.

Intralytix receives Safe Quality Food (SQF) certification

Intralytix announced today that it has received the highly coveted Safe Quality Food (SQF) certification for food manufacturing

Page 1 of 11

News Around the World

Intralytix: Revolutionizing Healthcare and Food Safety with Cutting-Edge Bacteriophage Technology

The leadership team at Intralytix, Inc. shares how their groundbreaking bacteriophage technology is redefining healthcare and food safety—earning them a spot on our cover and recognition as one of the Top Fastest Growing Companies to Watch in 2025

Intralytix: Food Safety in the 21st Century: Bacteriophage-based Biocontrol as an Emerging Green Technology for Improving Food Safety

Phage biocontrol - an emerging modern technology now going mainstream for improving food safety.

Intralytix: Leveraging Phage Power for Food Safety

Intralytix once again selected as 2024 “Top Food Safety Solutions Provider” by the Food and Beverage Technology Review magazine.

H.C. Wainwright & Co., LLC hosts the First Annual Bacteriophage Conference

On November 30, 2022, H.C. Wainwright & Co., LLC hosted the First Annual Bacteriophage Conference to highlight what H.C. Wainwright & Co. believes to be a major pending inflection point in the field. Intralytix was one of the phage companies featured at the conference, with our President and CEO, Dr. Alexander "Sandro" Sulakvelidze presenting.

The State of Phage Therapy

Bacteriophages could be crucial weapons in the fight against antibiotic-resistant bacteria.

Page 1 of 13